Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/31665| Title: | Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's disease. | Austin Authors: | Huang, Xin;Li, Yihan;Fowler, Christopher;Doecke, James D;Lim, Yen Ying;Drysdale, Candace;Zhang, Vicky;Park, Keunha;Trounson, Brett;Pertile, Kelly;Rumble, Rebecca;Pickering, John W;Rissman, Robert A;Sarsoza, Floyd;Abdel-Latif, Sara;Lin, Yong;Doré, Vincent ;Villemagne, Victor L ;Rowe, Christopher C ;Fripp, Jurgen;Martins, Ralph;Wiley, James S;Maruff, Paul;Mintzer, Jacobo E;Masters, Colin L ;Gu, Ben J | Affiliation: | The Florey Institute of Neuroscience and Mental Health The Australian e-Health Research Centre, CSIRO, Brisbane, Queensland, Australia. Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria, Australia. Department of Medicine, University of Otago, New Zealand and Department of Emergency Medicine, Christchurch Hospital, Christchurch, New Zealand. Department of Neurosciences, University of California, San Diego, California, USA. Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego, California, USA. National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China. The Australian e-Health Research Centre, CSIRO, Brisbane, Queensland, Australia. Department of Molecular Imaging & Therapy, Austin Health, Melbourne, Australia, and Department of Medicine, the University of Melbourne, Melbourne, Australia. Molecular Imaging and Therapy The Australian e-Health Research Centre, CSIRO, Brisbane, Queensland, Australia. Centre of Excellence for Alzheimer's Disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia. NeuroQuest, Inc., Medical University of South Carolina, South Carolina, USA. |
Issue Date: | May-2023 | Date: | 2022 | Publication information: | Alzheimer's & Dementia : the Journal of the Alzheimer's Association 2023-05; 19(5) | Abstract: | Blood-based diagnostics and prognostics in sporadic Alzheimer's disease (AD) are important for identifying at-risk individuals for therapeutic interventions. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/31665 | DOI: | 10.1002/alz.12813 | ORCID: | 0000-0001-5500-4453 | Journal: | Alzheimer's & Dementia : the Journal of the Alzheimer's Association | PubMed URL: | 36349985 | ISSN: | 1552-5279 | Type: | Journal Article | Subjects: | Alzheimer's disease CD11c CD163 CD59 CD91 ROC curve complement system innate phagocytosis leukocyte biomarker peripheral immune response receptor for advanced glycation end products (RAGE) |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.